Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025

生物分析試験サービスの世界市場予測:タイプ別(細胞ベースアッセイ、 ウイルス学試験、メソッド開発、最適化、検証、血清学、免疫原性、中和抗体、バイオマーカー試験、薬物動態試験)、用途別、エンドユーザー別

◆タイトル:Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025
◆商品コード:AST 7644
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年5月20日
◆ページ数:204
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:化学機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥529,650見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は生物分析試験サービスの世界市場が2020年21億ドルから2025年37億ドルまで、年平均11.8%成長すると予測しています。本調査レポートでは、生物分析試験サービスの世界市場を詳細に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別(細胞ベースアッセイ、ウイルス学試験、メソッド開発最適化&検証、血清&免疫原性&中和抗体、バイオマーカーテスト、薬物動態試験、その他)、用途別(オンコロジー、神経、感染症、胃腸科、循環器、その他)、エンドユーザー別(製薬&生物医薬品会社、コントラクト開発&製造組織、コントラクト研究組織)、地域別、競争状況、企業概要などを含め、ご提供いたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・生物分析試験サービスの世界市場:種類別(細胞ベースアッセイ、ウイルス学試験、メソッド開発最適化&検証、血清&免疫原性&中和抗体、バイオマーカーテスト、薬物動態試験、その他)
・生物分析試験サービスの世界市場:用途別(オンコロジー、神経、感染症、胃腸科、循環器、その他)
・生物分析試験サービスの世界市場:エンドユーザー別(製薬&生物医薬品会社、コントラクト開発&製造組織、コントラクト研究組織)
・生物分析試験サービスの世界市場:地域別
・競争状況
・企業概要

“Rising focus on the analytical testing of biologics and biosimilars to drive market growth”
The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is attributed to the rising focus on the analytical testing of biologics and biosimilars, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market during the forecast period.

“Pharmaceutical and biopharmaceutical companies were the largest end users of bioanalytical testing services in 2019″
Based on end user, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2019, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products.

“Oncology is the largest application segment in the bioanalytical testing services market”
Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

“North America will continue to dominate the bioanalytical testing services market in 2025″
The bioanalytical testing services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the bioanalytical testing services market. The large share of North America in this market can be attributed to the high-quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics markets, and an increase in clinical trial activity in the region.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
• By Designation – C-level: 30%, Director-level: 55%, and Others: 15%
• By Region – North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

The prominent players operating in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK).
Research Coverage:
The report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth potential of various market segments, based on type, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the bioanalytical testing services market. The report analyzes this market by type, application, end user, and region
 Market Development: Comprehensive information on the lucrative emerging markets, by type, application, end user, and region
 Market Diversification: Exhaustive information about the service portfolios, growing geographies, recent developments, and investments in the bioanalytical testing services market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the bioanalytical testing services market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 19)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 22)
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 30)

4 PREMIUM INSIGHTS (Page No. – 33)
4.1 BIOANALYTICAL TESTING SERVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION & COUNTRY (2019)
4.3 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: BIOANALYTICAL TESTING SERVICES MARKET
4.5 BIOANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW (Page No. – 38)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising focus on the analytical testing of biologics and biosimilars
5.2.1.2 Increasing preference for outsourcing analytical testing
5.2.1.3 Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
5.2.1.4 Rising adoption of the Quality by Design approach
5.2.2 RESTRAINTS
5.2.2.1 Dearth of skilled professionals
5.2.2.2 Pricing pressure faced by major players
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging countries in the Asia Pacific region
5.2.3.2 Rising demand for specialized bioanalytical testing services
5.2.4 CHALLENGES
5.2.4.1 Innovative formulations demanding a unique bioanalytical testing approach
5.2.4.2 Growing need to improve the sensitivity of bioanalytical methods

6 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE (Page No. – 45)
6.1 INTRODUCTION
6.2 CELL-BASED ASSAYS
6.2.1 BACTERIAL CELL-BASED ASSAYS
6.2.1.1 Bacterial cell-based assays segment to dominate the bioanalytical testing services market for cell-based assays
6.2.2 VIRAL CELL-BASED ASSAYS
6.2.2.1 Increasing outbreaks of viral diseases to support the growth of this market segment
6.3 VIROLOGY TESTING
6.3.1 IN VITRO VIROLOGY TESTING
6.3.1.1 Higher uptake of in vitro virology assays in the development of antiviral pharmaceuticals to drive the growth of this market segment
6.3.2 IN VIVO VIROLOGY TESTING
6.3.2.1 High utilization of in vivo assays during important production phases to drive their demand
6.3.3 SPECIES-SPECIFIC VIRAL PCR ASSAYS
6.3.3.1 Wide application of species-specific viral PCR assays in the detection of viral risks to support the growth of this market segment
6.4 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
6.4.1 MANDATORY REQUIREMENT BY REGULATORY AUTHORITIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.5 SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.5.1 INCREASING APPLICATIONS OF SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.5.2 BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.5.3 VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.6 BIOMARKER TESTING
6.6.1 EMPHASIS ON THE DEVELOPMENT OF PERSONALIZED MEDICINE TO DRIVE THE DEMAND FOR BIOMARKER TESTING SERVICES
6.7 PHARMACOKINETIC TESTING
6.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR PHARMACOKINETIC TESTING SERVICES
6.8 OTHER SERVICES

7 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION (Page No. – 62)
7.1 INTRODUCTION
7.2 ONCOLOGY
7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE BIOANALYTICAL TESTING SERVICES MARKET
7.3 NEUROLOGY
7.3.1 ROBUST PIPELINE OF DRUGS FOR CNS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
7.4 INFECTIOUS DISEASES
7.4.1 OUTBREAK OF COVID-19 TO BOOST THE GROWTH OF THIS MARKET SEGMENT
7.5 GASTROENTEROLOGY
7.5.1 RISING PREVALENCE OF CHRONIC DIGESTIVE DISORDERS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.6 CARDIOLOGY
7.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.7 OTHER APPLICATIONS

8 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER (Page No. – 73)
8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
8.2.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END USERS OF BIOANALYTICAL TESTING SERVICES
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
8.3.1 CDMOS PROVIDE SERVICES SUCH AS ANALYTICAL DEVELOPMENT, FORMULATION SCREENING AND DEVELOPMENT, STABILITY STUDIES, AND PRE-CLINICAL SAFETY ASSESSMENT STUDIES
8.4 CONTRACT RESEARCH ORGANIZATIONS
8.4.1 CONTRACT RESEARCH ORGANIZATIONS ARE INCREASINGLY SUBCONTRACTING THEIR ACTIVITIES TO NICHE LABORATORIES SPECIALIZED IN PROVIDING BIOANALYTICAL TESTING SERVICES

9 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION (Page No. – 80)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US is the largest market for bioanalytical testing services in North America
9.2.2 CANADA
9.2.2.1 Increasing number of clinical trials in Canada to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Government support and flexible labor laws have made Germany a favorable location for clinical trials
9.3.2 FRANCE
9.3.2.1 High number of oncology clinical trials in France to drive market growth
9.3.3 UK
9.3.3.1 Investment by pharmaceutical sponsors in the UK for drug discovery services to support market growth
9.3.4 ITALY
9.3.4.1 Low drug approval time in Italy, along with the growing number of clinical trials, to drive market growth
9.3.5 SPAIN
9.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 China is the largest market for bioanalytical testing services in the Asia Pacific
9.4.2 JAPAN
9.4.2.1 Rising geriatric population to drive market growth in Japan
9.4.3 INDIA
9.4.3.1 Growing pharmaceutical industry in India to drive market growth
9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA

10 COMPETITIVE LANDSCAPE (Page No. – 131)
10.1 INTRODUCTION
10.2 COMPETITIVE LEADERSHIP MAPPING
10.2.1 VISIONARY LEADERS
10.2.2 INNOVATORS
10.2.3 DYNAMIC DIFFERENTIATORS
10.2.4 EMERGING COMPANIES
10.3 BIOANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS
10.4 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL ASSESSMENT
10.5 COMPETITIVE SITUATIONS & TRENDS
10.5.1 SERVICE LAUNCHES (2017–2020)
10.5.2 EXPANSIONS (2019–2020)
10.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2019–2020)
10.5.4 ACQUISITIONS (2019)
10.5.5 OTHER DEVELOPMENTS (2019)

11 COMPANY PROFILES (Page No. – 139)
(Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View)*
11.1 CHARLES RIVER
11.2 MEDPACE
11.3 WUXI APPTEC
11.4 EUROFINS SCIENTIFIC
11.5 IQVIA INC.
11.6 SGS SA
11.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
11.8 INTERTEK GROUP PLC
11.9 PRA HEALTH SCIENCES
11.10 SYNEOS HEALTH
11.11 ICON PLC
11.12 FRONTAGE LABS
11.13 PPD, INC.
11.14 PAREXEL INTERNATIONAL CORPORATION
11.15 ALMAC GROUP
11.16 CELERION
11.17 ALTASCIENCES
11.18 BIOAGILYTIX LABS
11.19 LOTUS LABS PVT. LTD.
11.20 LGC LIMITED
*Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View might not be captured in case of unlisted companies.



★調査レポート[生物分析試験サービスの世界市場予測:タイプ別(細胞ベースアッセイ、 ウイルス学試験、メソッド開発、最適化、検証、血清学、免疫原性、中和抗体、バイオマーカー試験、薬物動態試験)、用途別、エンドユーザー別] ( Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025 / AST 7644) 販売に関する免責事項
[生物分析試験サービスの世界市場予測:タイプ別(細胞ベースアッセイ、 ウイルス学試験、メソッド開発、最適化、検証、血清学、免疫原性、中和抗体、バイオマーカー試験、薬物動態試験)、用途別、エンドユーザー別] ( Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025 / AST 7644) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆